Biotech companies in the United States by P/E ratio

Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.

Exelixis has the lowest figure of the 7 biotech companies in the United States ranked by P/E ratio, at 19.7, followed by Neurocrine Biosciences (23.2) and Halozyme Therapeutics (23.3). Figures as of 20 Nov 2026, 14:06 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
7
Lowest
Exelixis19.7
Median
25.4
Combined market value
PLN 2.98T
Countries
1
Not ranked
13no P/E ratio on file

Market values as of .

United States
All sectors
Biotech
PLN
Clear filters
Biotech companies in the United States by P/E ratio
#CompanyP/E ↑Market capPriceToday1 yearPrice, 30 daysCountry
1ExelixisEXEL · Health Care19.7PLN 65.1BPLN 266.75 3.60% down 55% up United States
2Neurocrine BiosciencesNBIX · Health Care23.2PLN 64.2BPLN 634.53 3.85% down 10% up United States
3Halozyme TherapeuticsHALO · Health Care23.3PLN 43BPLN 377.01 2.88% down 32% up United States
4AmgenAMGN · Health Care25.4PLN 961.8BPLN 1,778.16 1.14% down 30% up United States
5Krystal BiotechKRYS · Health Care42.9PLN 37.9BPLN 1,279.75 0.15% up 49% up United States
6Bio-TechneTECH · Health Care66.7PLN 46.3BPLN 294.59 0.07% down 18% up United States
7BiogenBIIB · Health Care107PLN 148BPLN 1,001.41 1.70% down 41% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0522 PLN). 13 companies have no P/E ratio on file and are not ranked here.

Questions and answers

Which biotech companies in the United States have the lowest P/E ratio?

Exelixis (19.7), Neurocrine Biosciences (23.2) and Halozyme Therapeutics (23.3) have the lowest P/E ratio of the 7 biotech companies in the United States ranked here as of 20 Nov 2026, 14:06 UTC.

How many biotech companies in the United States are in this ranking?

7 are ranked by P/E ratio. 13 more have no P/E ratio on file and are left out rather than ranked at zero.

What are these biotech companies in the United States worth together?

The 7 biotech companies in the United States ranked by P/E ratio have a combined market value of PLN 2.98T as of 20 Nov 2026, 14:06 UTC.

What does ranking by P/E ratio measure?

Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.

Cite this page

Funkfolio, “Biotech companies in the United States by P/E ratio”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=pe-ratio

Underlying data: Yahoo Finance; SEC EDGAR.